Johnson & Johnson
JNJ
#19
Rank
S$740.69 B
Marketcap
S$307.36
Share price
-1.79%
Change (1 day)
44.05%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2024: S$120.73 Billion

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM ) is S$116.79 Billion. In 2024 the company made a revenue of S$120.73 Billion an increase over the revenue in the year 2023 that were of S$112.46 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2024

Annual revenue

Year Revenue Change
2024S$120.73 B7.35%
2023S$112.46 B-7.96%
2022S$122.19 B-3.61%
2021S$126.77 B16.04%
2020S$109.25 B-1.24%
2019S$110.63 B-0.74%
2018S$111.45 B9%
2017S$102.25 B-1.72%
2016S$104.04 B4.97%
2015S$99.12 B0.92%
2014S$98.21 B8.71%
2013S$90.35 B9.9%
2012S$82.20 B-2.39%
2011S$84.21 B6.16%
2010S$79.33 B-8.71%
2009S$86.89 B-4.68%
2008S$91.16 B3.7%
2007S$87.91 B7.52%
2006S$81.76 B-2.78%
2005S$84.10 B8.88%
2004S$77.24 B8.6%
2003S$71.12 B12.93%
2002S$62.98 B4.7%
2001S$60.15 B17.52%
2000S$51.18 B10.49%
1999S$46.32 B18.61%
1998S$39.05 B2.37%
1997S$38.15 B26.09%
1996S$30.25 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
S$71.83 B-38.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$79.58 B-31.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$55.57 B-52.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$44.05 B-62.28%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$75.31 B-35.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$60.23 B-48.43%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
S$36.86 B-68.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
S$30.90 B-73.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$81.41 B-30.29%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$53.68 B-54.04%๐Ÿ‡ฌ๐Ÿ‡ง UK